This webinar will review how recent advances in the understanding of CIDP pathophysiology are shaping the development and use of targeted therapies, examine emerging clinical trial and real-world evidence on targeted treatment approaches and their implications for long-term disease management and discuss how biomarkers and patient-centered outcome measures may support treatment monitoring, assessment of disease activity, and more individualized therapeutic decision-making.
Date: 26 November 2026
Time: 18:00-19:30 CET
Topic: Neuropathies
Chair: Eva Solé Cruz
Speakers: Krista Kuitwaard, Nicolas Dubuisson, Luis Querol
This webinar is supported by un unrestricted educational grant from argenx.
For more information and to register, please click the LINK
__________________________________
